Oxysure (OXYS) is a medical technology company and one of the top five fastest growing companies in Texas. It has been listed as a top stock to watch by MarketWatch.
Frisco, TX -First responder technologies are in growing demand today, in both civilian and military contexts. Companies like OxySure Systems Inc. (OXYS) are growing steadily to meet this demand. Their launch product, the OxySure Model 615, provides a unique solution for emergency responders who require medically pure oxygen in high stress, dynamic medical situations. The platform technology creates medically pure oxygen using dry, inert powders. This is revolutionary and will increase medical outcomes. The model requires no compression tanks, dials, or even regulatory maintenance as oxygen equipment would ordinarily. The product's simplicity requires no special medical or safety training and is safe and easy-to-use for the layperson. The company size of the products enable them to be placed anywhere a medical emergency might occur. The addition of pure oxygen is known to help improve medical outcomes, and thus saving lives by reducing and bridging the gap between a medical emergency and the arrival of first responders on the scene. This type of emergency equipment will help to save lives, reduce liability, and assist first responders.
Companies that can provide medical solutions, especially those which are safe, portable, and can show immediate “value added” do well even in tremulous markets. Stock watch companies have put Oxysure (OXYS) on their list of products and companies to watch in the near future. The company has had 12 consecutive quarters of growth with five of those quarters with triple-digit growth and six at double digit. TTM Revenue is at $2.71 million with margins of 56% - 62%. The average annual growth rate over 3 years is at 216% with an average quarterly growth rate of 260% over 12 quarters 260%. This is a company that should prove to be not only a safe investment but lucrative.
For more information: http://www.oxysure.com/aed/oxys-ir/ir/
About OxySure Systems, Inc.
OxySure Systems, Inc. (OTCQB: OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. In addition to oxygen products for public/lay responder usage, OxySure also markets emergency medical solutions including AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and Heartsine), QuikClot Bleeding Control solutions, resuscitation products and pulse oximetry products. www.OxySure.com
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2014.
Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone
Tel.: (416) 644-2020 or (514) 939-3989
bfilippone@renmarkfinancial.com
www.renmarkfinancial.com
Redchip Companies, Inc.
Jon Cunningham
800-733-2447, ext. 107
jon@redchip.com
www.redchip.com
View full press release